QM/MM based 3D QSAR models for potent B-Raf inhibitors

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• B-Raf inhibitors are crucial in cancer therapy.
• Understanding structure-activity relationships is key for drug design.
• Pyrazole derivatives show promise as B-Raf inhibitors.

Purpose of the Study:

• To develop robust 3D quantitative structure-activity relationship (QSAR) models for pyrazole-based B-Raf inhibitors.
• To identify key structural features influencing B-Raf inhibitor activity.
• To guide the design of novel, potent B-Raf inhibitors.

Main Methods:

• Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) were employed.
• Receptor-guided alignment with QM/MM minimization was used for model generation.
• Models were validated using external test sets and contour map analysis.

Main Results:

• The best CoMFA model achieved q(2)=0.624 and r(2)=0.959; the best CoMSIA model achieved q(2)=0.590 and r(2)=0.922.
• External validation yielded predictive r(2) values of 0.926 (CoMFA) and 0.878 (CoMSIA).
• Contour maps highlighted critical structural elements for activity and receptor-ligand interactions.

Conclusions:

• The developed QSAR models provide reliable predictions for B-Raf inhibitor activity.
• Identified structural insights and novel fragments can inform the design of next-generation B-Raf inhibitors.
• This research facilitates the development of more effective cancer therapeutics.